187 related articles for article (PubMed ID: 9454733)
1. Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi.
Engel JC; Doyle PS; Palmer J; Hsieh I; Bainton DF; McKerrow JH
J Cell Sci; 1998 Mar; 111 ( Pt 5)():597-606. PubMed ID: 9454733
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the secretory pathway in cysteine protease inhibitor-resistant Trypanosoma cruzi.
Engel JC; Torres C; Hsieh I; Doyle PS; McKerrow JH
J Cell Sci; 2000 Apr; 113 ( Pt 8)():1345-54. PubMed ID: 10725218
[TBL] [Abstract][Full Text] [Related]
3. A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi.
Barr SC; Warner KL; Kornreic BG; Piscitelli J; Wolfe A; Benet L; McKerrow JH
Antimicrob Agents Chemother; 2005 Dec; 49(12):5160-1. PubMed ID: 16304193
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.
Chen YT; Brinen LS; Kerr ID; Hansell E; Doyle PS; McKerrow JH; Roush WR
PLoS Negl Trop Dis; 2010 Sep; 4(9):. PubMed ID: 20856868
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases.
Yong V; Schmitz V; Vannier-Santos MA; de Lima AP; Lalmanach G; Juliano L; Gauthier F; Scharfstein J
Mol Biochem Parasitol; 2000 Jun; 109(1):47-59. PubMed ID: 10924756
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: insights into naphthoquinone effects on growth and proteinase activity.
Bourguignon SC; Cavalcanti DF; de Souza AM; Castro HC; Rodrigues CR; Albuquerque MG; Santos DO; da Silva GG; da Silva FC; Ferreira VF; de Pinho RT; Alves CR
Exp Parasitol; 2011 Jan; 127(1):160-6. PubMed ID: 20647011
[TBL] [Abstract][Full Text] [Related]
7. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.
Lima AP; dos Reis FC; Serveau C; Lalmanach G; Juliano L; Ménard R; Vernet T; Thomas DY; Storer AC; Scharfstein J
Mol Biochem Parasitol; 2001 Apr; 114(1):41-52. PubMed ID: 11356512
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses.
Lameiro RF; Montanari CA
ChemMedChem; 2023 Mar; 18(6):e202200434. PubMed ID: 36692246
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of cruzain: a therapeutic target for Chagas' disease.
McGrath ME; Eakin AE; Engel JC; McKerrow JH; Craik CS; Fletterick RJ
J Mol Biol; 1995 Mar; 247(2):251-9. PubMed ID: 7707373
[TBL] [Abstract][Full Text] [Related]
10. The Trypanosoma cruzi protease cruzain mediates immune evasion.
Doyle PS; Zhou YM; Hsieh I; Greenbaum DC; McKerrow JH; Engel JC
PLoS Pathog; 2011 Sep; 7(9):e1002139. PubMed ID: 21909255
[TBL] [Abstract][Full Text] [Related]
11. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.
Doyle PS; Zhou YM; Engel JC; McKerrow JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):3932-9. PubMed ID: 17698625
[TBL] [Abstract][Full Text] [Related]
12. Novel cruzain inhibitors for the treatment of Chagas' disease.
Rogers KE; Keränen H; Durrant JD; Ratnam J; Doak A; Arkin MR; McCammon JA
Chem Biol Drug Des; 2012 Sep; 80(3):398-405. PubMed ID: 22613098
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
Scheidt KA; Roush WR; McKerrow JH; Selzer PM; Hansell E; Rosenthal PJ
Bioorg Med Chem; 1998 Dec; 6(12):2477-94. PubMed ID: 9925304
[TBL] [Abstract][Full Text] [Related]
14. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Novel Inhibitors of Cruzain Cysteine Protease of
Prates JLB; Lopes JR; Chin CM; Ferreira EI; Dos Santos JL; Scarim CB
Curr Med Chem; 2024; 31(16):2285-2308. PubMed ID: 37888814
[TBL] [Abstract][Full Text] [Related]
16. Computational approaches towards the discovery and optimisation of cruzain inhibitors.
Santos VC; Ferreira RS
Mem Inst Oswaldo Cruz; 2022; 117():e210385. PubMed ID: 35293427
[TBL] [Abstract][Full Text] [Related]
17. Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain.
Roush WR; Cheng J; Knapp-Reed B; Alvarez-Hernandez A; McKerrow JH; Hansell E; Engel JC
Bioorg Med Chem Lett; 2001 Oct; 11(20):2759-62. PubMed ID: 11591518
[TBL] [Abstract][Full Text] [Related]
18. Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells.
Santos CC; Sant'anna C; Terres A; Cunha-e-Silva NL; Scharfstein J; de A Lima AP
J Cell Sci; 2005 Mar; 118(Pt 5):901-15. PubMed ID: 15713748
[TBL] [Abstract][Full Text] [Related]
19. Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach.
Hernández Alvarez L; Barreto Gomes DE; Hernández González JE; Pascutti PG
PLoS One; 2019; 14(1):e0211227. PubMed ID: 30682119
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of dipeptidyl alpha',beta'-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzain.
Roush WR; González FV; McKerrow JH; Hansell E
Bioorg Med Chem Lett; 1998 Oct; 8(19):2809-12. PubMed ID: 9873627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
